Myelodysplastic syndrome diagnosed by genetic testing for hereditary cancer: a case report
Abstract Genetic testing for solid tumor syndromes typically uses peripheral blood leukocytes (PBL) as the source of germline DNA. This approach has shortcomings in certain situations, such as somatic mosaicism and hematologic malignancies. Here we describe a case where germline genetic testing on P...
Saved in:
| Main Authors: | Sarah Ridd, Larissa Peck, Aniket Bankar, George S. Charames, Jordan Lerner-Ellis, Radhika Mahajan, Peter J. B. Sabatini, Andrew Wong, Janet Malcolmson, Raymond H. Kim |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | npj Genomic Medicine |
| Online Access: | https://doi.org/10.1038/s41525-025-00476-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
P755: The impact of gene-specific guidelines on variant reassessment: Perspectives from a hereditary cancer clinic
by: Nina Anggala, et al.
Published: (2025-01-01) -
Recurrence of minimal residual disease in acute myeloid leukemia: a window of opportunity for intervention
by: Aniket Bankar
Published: (2025-07-01) -
Germline and somatic genetic landscape of pediatric myelodysplastic syndromes
by: Lili Kotmayer, et al.
Published: (2025-06-01) -
Ultrasound combined with molecular genetics to diagnose hereditary Renpenning syndrome in early pregnancy: a case report
by: Yongmei Shen, et al.
Published: (2025-07-01) -
Treatment of Vietnamese patients diagnosed with myelodysplastic neoplasms: Practical experience in a developing country
by: Quang Hao Nguyen, et al.
Published: (2025-01-01)